SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-23-091498
Filing Date
2023-08-14
Accepted
2023-08-14 17:11:09
Documents
4
Period of Report
2023-10-02

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2323689d1_def14a.htm DEF 14A 432912
2 GRAPHIC tm2323689d1_def14aimg001.jpg GRAPHIC 2374
3 GRAPHIC tm2323689d1_def14aimg002.jpg GRAPHIC 136758
4 GRAPHIC tm2323689d1_def14aimg003.jpg GRAPHIC 94386
  Complete submission text file 0001104659-23-091498.txt   756312
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12584 | Film No.: 231171909
SIC: 2834 Pharmaceutical Preparations